Skip Navigation


American Journal of Epidemiology Advance Access originally published online on February 6, 2007
American Journal of Epidemiology 2007 165(9):1047-1054; doi:10.1093/aje/kwk093
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
165/9/1047    most recent
kwk093v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jehn, M. L.
Right arrow Articles by Pankow, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jehn, M. L.
Right arrow Articles by Pankow, J. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Copyright © 2007 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A.

ORIGINAL CONTRIBUTIONS

A Prospective Study of Plasma Ferritin Level and Incident Diabetes

The Atherosclerosis Risk in Communities (ARIC) Study

Megan L. Jehn1,2, Eliseo Guallar1,3, Jeanne M. Clark1,3, David Couper4, Bruce B. Duncan5, Christie M. Ballantyne6, Ron C. Hoogeveen6, Z. Leah Harris7 and James S. Pankow8

1 Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD
2 School of Health Management and Policy, W. P. Carey School of Business, Arizona State University, Tempe, AZ
3 Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD
4 Department of Biostatistics, School of Public Health, University of North Carolina, Chapel Hill, NC
5 Graduate Studies Program in Epidemiology, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
6 Department of Medicine, Center for Cardiovascular Disease Prevention, Baylor College of Medicine, Houston, TX
7 Department of Anesthesiology, Johns Hopkins Medical Institutions, Baltimore, MD
8 Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN

Correspondence to Dr. Eliseo Guallar, Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Medical Institutions, 2024 East Monument Street, Room 2-639, Baltimore, MD 21205 (e-mail: eguallar{at}jhsph.edu).

Received for publication June 12, 2006. Accepted for publication October 11, 2006.

The authors performed a case-cohort study nested within the Atherosclerosis Risk in Communities (ARIC) Study to determine the association between plasma ferritin level and risk of type 2 diabetes mellitus. Persons with incident cases of type 2 diabetes diagnosed over an average follow-up period of 7.9 years (n = 599) were compared with a random sample of the cohort (n = 690). After adjustment for age, gender, menopausal status, ethnicity, center, smoking, and alcohol intake, the hazard ratio for diabetes, comparing the fifth quintile of ferritin with the first quintile, was 1.74 (95% confidence interval: 1.14, 2.65; p-trend < 0.001). After further adjustment for body mass index and components of the metabolic syndrome, the hazard ratio was 0.81 (95% confidence interval: 0.49, 1.34; p-trend = 0.87). From a causal perspective, there are two alternative interpretations of these findings. Elevated iron stores, reflected in elevated plasma ferritin levels, may induce baseline metabolic abnormalities that ultimately result in diabetes. Alternatively, elevated ferritin may be just one of several metabolic abnormalities related to the underlying process that ultimately results in diabetes, rather than a causal factor for diabetes. Longitudinal studies with repeated measurements of glucose and iron metabolism parameters are needed to establish the role of iron stores and plasma ferritin in diabetes development.

cohort studies; diabetes mellitus, type 2; ferritins; incidence; iron


Abbreviations: ARIC, Atherosclerosis Risk in Communities; CI, confidence interval


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BMJHome page
S. Stranges and E. Guallar
Dietary iron and blood pressure
BMJ, July 15, 2008; 337(jul15_1): a547 - a547.
[Full Text]


Home page
Diabetes CareHome page
H. Zheng, M. Patel, R. Cable, L. Young, and S. D. Katz
Insulin Sensitivity, Vascular Function, and Iron Stores in Voluntary Blood Donors
Diabetes Care, October 1, 2007; 30(10): 2685 - 2689.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Swaminathan, V. A. Fonseca, M. G. Alam, and S. V. Shah
The Role of Iron in Diabetes and Its Complications
Diabetes Care, July 1, 2007; 30(7): 1926 - 1933.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.